Nu Med's market value is the price at which a share of Nu Med trades on a public exchange. It measures the collective expectations of Nu Med Plus investors about its performance. Nu Med is trading at 0.0142 as of the 1st of February 2026, a 29 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0142. With this module, you can estimate the performance of a buy and hold strategy of Nu Med Plus and determine expected loss or profit from investing in Nu Med over a given investment horizon. Check out Nu Med Correlation, Nu Med Volatility and Nu Med Performance module to complement your research on Nu Med.
It's important to distinguish between Nu Med's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nu Med should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Nu Med's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Nu Med 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nu Med's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nu Med.
0.00
11/03/2025
No Change 0.00
0.0
In 3 months and 1 day
02/01/2026
0.00
If you would invest 0.00 in Nu Med on November 3, 2025 and sell it all today you would earn a total of 0.00 from holding Nu Med Plus or generate 0.0% return on investment in Nu Med over 90 days. Nu Med is related to or competes with Talis Biomedical, USA Equities, and Kelyniam Global. Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of m... More
Nu Med Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nu Med's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nu Med Plus upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nu Med's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nu Med's standard deviation. In reality, there are many statistical measures that can use Nu Med historical prices to predict the future Nu Med's volatility.
Nu Med Plus retains Efficiency (Sharpe Ratio) of -0.0949, which conveys that the firm had a -0.0949 % return per unit of price deviation over the last 3 months. Nu Med exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nu Med's Information Ratio of (0.1), market risk adjusted performance of (0.45), and Mean Deviation of 3.38 to check out the risk estimate we provide. The company owns a Beta (Systematic Risk) of 1.72, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nu Med will likely underperform. At this point, Nu Med Plus has a negative expected return of -0.81%. Please make sure to verify Nu Med's variance and the relationship between the value at risk and relative strength index , to decide if Nu Med Plus performance from the past will be repeated at future time.
Auto-correlation
-0.22
Weak reverse predictability
Nu Med Plus has weak reverse predictability. Overlapping area represents the amount of predictability between Nu Med time series from 3rd of November 2025 to 18th of December 2025 and 18th of December 2025 to 1st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nu Med Plus price movement. The serial correlation of -0.22 indicates that over 22.0% of current Nu Med price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.22
Spearman Rank Test
-0.24
Residual Average
0.0
Price Variance
0.0
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Nu-Med OTC Stock
Nu Med financial ratios help investors to determine whether Nu-Med OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nu-Med with respect to the benefits of owning Nu Med security.